JENNA GUNSELMAN: Open Payments
NPI 1538523162 · GALLATIN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 88 payments from 26 companies in 2025. Trend: 2023 $1,735 · 2024 $1,010 · 2025 $1,809
Food & beverage: $1,809
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 9 | $174 |
| Corcept Therapeutics | 7 | $171 |
| Amgen Inc. | 11 | $162 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $120 |
| Lilly USA, LLC | 9 | $120 |
| Abbott Laboratories | 2 | $108 |
| ABBVIE INC. | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 6 | $94 |
| Xeris Pharmaceuticals, Inc. | 4 | $85 |
| Verona Pharma, Inc. | 3 | $82 |
Products named: Korlym, OTEZLA, CAPLYTA, MOUNJARO, FREESTYLE LIBRE 3, GVOKE HYPOPEN, Ohtuvayre, LEQVIO.
Industry payments across TN — which companies pay providers there.
